











It is often necessary to use multiple assays with various readouts to detect toxicity to different cell types. LumiSTEM™, LUMENESC™ and HALO® all use the same ATP-based bioluminescnce signal detection system. HemoGenix® has combined its three platforms into a single, unique and extremely powerful predictive toxicity platform called ComparaTOX™ - Predictive In Vitro Cross-Platform Comparative Toxicity Testing.
The LumiSTEM™-96 or LumiSTEM™-384 Platform can incorporate and test any of the cells listed below in side-by-side assays. This is the list which HemoGenix® uses for its Contract Research Services. Despite the fact that these cell types require different culture conditions, they can all be tested for their response to toxic agents using LumiSTEM™.